VA's Pharmacy Prime Vendor Contract with McKesson Corporation Totals $14.9M, Awarded Under Full and Open Competition
Contract Overview
Contract Amount: $14,932,682 ($14.9M)
Contractor: Mckesson Corporation
Awarding Agency: Department of Veterans Affairs
Start Date: 2009-09-01
End Date: 2009-09-30
Contract Duration: 29 days
Daily Burn Rate: $514.9K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 1
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: EXPRESS REPORT PHARMACY PRIME VENDOR
Place of Performance
Location: BEDFORD, MIDDLESEX County, MASSACHUSETTS, 01730
Plain-Language Summary
Department of Veterans Affairs obligated $14.9 million to MCKESSON CORPORATION for work described as: EXPRESS REPORT PHARMACY PRIME VENDOR Key points: 1. The contract, valued at $14.9 million, was awarded to McKesson Corporation. 2. Competition was full and open, suggesting a competitive bidding process. 3. The contract duration was 29 days, indicating a short-term or interim award. 4. The spending falls under the 'Drugs and Druggists' Sundries Merchant Wholesalers' NAICS code.
Value Assessment
Rating: good
The contract value of $14.9 million for a 29-day period suggests a significant but potentially short-term need. Without specific unit pricing or comparison to similar short-term pharmacy vendor contracts, a precise pricing assessment is difficult, but the full and open competition implies a focus on achieving a competitive price.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, which typically allows all responsible sources to submit a bid. This method is designed to promote price discovery and ensure the government receives the best value by fostering a competitive environment.
Taxpayer Impact: The use of full and open competition is generally favorable for taxpayers as it aims to secure competitive pricing and avoid inflated costs associated with limited or sole-source procurements.
Public Impact
Ensures access to essential pharmaceuticals for veterans. Supports the Department of Veterans Affairs' healthcare mission. Potential for cost savings due to competitive bidding. Reliability of drug supply chain for VA facilities.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Short contract duration (29 days) may indicate an interim solution or a specific, limited-time requirement.
- Lack of detailed breakdown of spending by drug category or service.
Positive Signals
- Awarded under full and open competition, promoting fairness and potential cost savings.
- Awarded to a known entity (McKesson Corporation) with established supply chain capabilities.
Sector Analysis
This contract falls within the healthcare sector, specifically related to pharmaceutical procurement. Spending benchmarks for pharmacy prime vendor contracts can vary widely based on the volume of prescriptions, types of drugs, and the specific needs of the agency. The $14.9 million for a 29-day period represents a substantial expenditure for a short timeframe.
Small Business Impact
The data does not indicate any specific set-asides for small businesses. As this was a full and open competition, larger prime vendors likely dominated the bidding process, though subcontractors could potentially include small businesses.
Oversight & Accountability
The Department of Veterans Affairs is responsible for overseeing this contract. Oversight would typically involve ensuring timely delivery, product quality, and adherence to contract terms. The short duration might imply less extensive long-term oversight is required compared to multi-year contracts.
Related Government Programs
- Drugs and Druggists' Sundries Merchant Wholesalers
- Department of Veterans Affairs Contracting
- Department of Veterans Affairs Programs
Risk Flags
- Short contract duration.
- Potential for price fluctuations in pharmaceutical markets.
- Dependence on a single vendor for a critical supply.
- Limited data on specific drug costs and volumes.
Tags
drugs-and-druggists-sundries-merchant-wh, department-of-veterans-affairs, ma, do, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Veterans Affairs awarded $14.9 million to MCKESSON CORPORATION. EXPRESS REPORT PHARMACY PRIME VENDOR
Who is the contractor on this award?
The obligated recipient is MCKESSON CORPORATION.
Which agency awarded this contract?
Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).
What is the total obligated amount?
The obligated amount is $14.9 million.
What is the period of performance?
Start: 2009-09-01. End: 2009-09-30.
What was the primary driver for the short 29-day duration of this contract?
The short 29-day duration suggests this contract may have served as an interim solution to bridge a gap between longer-term contracts, fulfilled an immediate and specific need, or was part of a phased procurement strategy. Without further context, it's difficult to pinpoint the exact reason, but it implies a non-standard or temporary requirement.
How did the pricing achieved through full and open competition compare to historical or projected costs for similar pharmaceutical supplies?
While full and open competition is designed to achieve competitive pricing, the provided data lacks specific cost comparisons. To assess value, one would need to analyze the per-unit costs of key pharmaceuticals against market benchmarks or previous contract pricing. The $14.9 million total for 29 days is significant, but its cost-effectiveness hinges on the specific drugs and quantities procured.
What is the potential impact on veteran healthcare access if this vendor experienced supply chain disruptions?
Given McKesson Corporation's established role as a major pharmaceutical distributor, the risk of significant supply chain disruption is generally considered low. However, any interruption could impact the availability of critical medications for veterans, potentially leading to treatment delays or the need for alternative, possibly more expensive, sourcing methods.
Industry Classification
NAICS: Wholesale Trade › Drugs and Druggists' Sundries Merchant Wholesalers › Drugs and Druggists' Sundries Merchant Wholesalers
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Offers Received: 1
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: 1 POST ST, SAN FRANCISCO, CA, 90
Business Categories: Category Business, Not Designated a Small Business
Financial Breakdown
Contract Ceiling: $14,932,682
Exercised Options: $14,932,682
Current Obligation: $14,932,682
Parent Contract
Parent Award PIID: V797P1020
IDV Type: IDC
Timeline
Start Date: 2009-09-01
Current End Date: 2009-09-30
Potential End Date: 2009-09-30 00:00:00
Last Modified: 2009-12-12
More Contracts from Mckesson Corporation
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 November — $1.4B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 October — $1.2B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2025 September — $1.2B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2025 July — $1.1B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 December — $1.1B (Department of Veterans Affairs)
Other Department of Veterans Affairs Contracts
- CCN Region 3 Express Report — $5.2B (Optum Public Sector Solutions, Inc.)
- Express Report for FY22 Region 2 — $5.1B (Optum Public Sector Solutions, Inc.)
- Fiscal Year 2022 Express Report for Region 1 — $4.2B (Optum Public Sector Solutions, Inc.)
- Express Report for the Patient Centered Community Care (PC3) Contract — $3.3B (Triwest Healthcare Alliance Corp)
- CCN Region Three FY21 Express Report — $3.1B (Optum Public Sector Solutions, Inc.)